{"transactions":[{"id":4634440,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-03T00:54:52.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":9.4073,"value":47036.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.210 to $9.670, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1351053,"source":{"system":"sec-edgar","filing":"0001867096-26-000086","document":"wk-form4_1790974489.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000186709626000086/wk-form4_1790974489.xml","form_type":"4"}},{"id":4634179,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-03T00:54:34.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":9.408,"value":141120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.180 to $9.665, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1599208,"source":{"system":"sec-edgar","filing":"0001867096-26-000085","document":"wk-form4_1790974469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709626000085/wk-form4_1790974469.xml","form_type":"4"}},{"id":4635440,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-03T00:54:14.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":16666,"price":9.4079,"value":156792.0614,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.180 to $9.680, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1111130,"source":{"system":"sec-edgar","filing":"0001867096-26-000084","document":"wk-form4_1790974451.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000186709626000084/wk-form4_1790974451.xml","form_type":"4"}},{"id":4628400,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-29T20:59:34.000Z","date":"2026-09-28","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":10,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."}],"balance_after":1614208,"source":{"system":"sec-edgar","filing":"0001867096-26-000078","document":"wk-form4_1790715570.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709626000078/wk-form4_1790715570.xml","form_type":"4"}},{"id":671416,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-01T22:21:17.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":8.4872,"value":127308.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.390 to $8.600, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1639208,"source":{"system":"sec-edgar","filing":"0002031695-26-000011","document":"wk-form4_1788301275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000011/wk-form4_1788301275.xml","form_type":"4"}},{"id":670806,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-01T22:21:06.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":16666,"price":8.4864,"value":141434.3424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.390 to $8.600, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1127796,"source":{"system":"sec-edgar","filing":"0001652410-26-000018","document":"wk-form4_1788301263.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000018/wk-form4_1788301263.xml","form_type":"4"}},{"id":671330,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-01T22:20:52.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":8.5,"value":42500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":1356053,"source":{"system":"sec-edgar","filing":"0001875714-26-000012","document":"wk-form4_1788301249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000012/wk-form4_1788301249.xml","form_type":"4"}},{"id":678559,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-21T20:23:22.000Z","date":"2026-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":36645,"price":8.08,"value":296091.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2026."}],"balance_after":2898933,"source":{"system":"sec-edgar","filing":"0001867096-26-000073","document":"wk-form4_1787343799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000186709626000073/wk-form4_1787343799.xml","form_type":"4"}},{"id":679085,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-21T20:15:33.000Z","date":"2026-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":21918,"price":8.08,"value":177097.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2026."}],"balance_after":1654208,"source":{"system":"sec-edgar","filing":"0001867096-26-000069","document":"wk-form4_1787343331.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709626000069/wk-form4_1787343331.xml","form_type":"4"}},{"id":689399,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-12T20:44:39.000Z","date":"2026-08-12","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":8.5,"value":42500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":1361053,"source":{"system":"sec-edgar","filing":"0001875714-26-000009","document":"wk-form4_1786567474.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000009/wk-form4_1786567474.xml","form_type":"4"}},{"id":697534,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-04T21:30:27.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":8.016,"value":120240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.000 to $8.150, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1676126,"source":{"system":"sec-edgar","filing":"0001867096-26-000059","document":"wk-form4_1785879024.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709626000059/wk-form4_1785879024.xml","form_type":"4"}},{"id":696789,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-04T21:16:23.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":16666,"price":8.0135,"value":133552.991,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.870 to $8.140, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1144462,"source":{"system":"sec-edgar","filing":"0001652410-26-000016","document":"wk-form4_1785878178.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000016/wk-form4_1785878178.xml","form_type":"4"}},{"id":713723,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-07T21:11:25.000Z","date":"2026-07-07","kind":"sale","planned":true,"acquired":false,"shares":27600,"price":8.5245,"value":235276.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.50 to $8.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1366053,"source":{"system":"sec-edgar","filing":"0001875714-26-000007","document":"wk-form4_1783458682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000007/wk-form4_1783458682.xml","form_type":"4"}},{"id":713722,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-07T21:11:25.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":17400,"price":8.5,"value":147900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,113 shares acquired on June 30, 2026 under the issuer's 2018 Employee Stock Purchase Plan, as amended."}],"balance_after":1393653,"source":{"system":"sec-edgar","filing":"0001875714-26-000007","document":"wk-form4_1783458682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000007/wk-form4_1783458682.xml","form_type":"4"}},{"id":717094,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":32607,"kind":"person","name":"KREHER NERISSA","position":1,"cik":"0001741850","reported_name":"KREHER NERISSA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T22:01:55.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":37910,"price":8,"value":303280.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service on the Company's Board of Directors through such vesting date."}],"balance_after":37910,"derivative":{"exercise_price":8,"expiration_date":"2036-07-01","underlying":"Common Stock","underlying_shares":37910},"source":{"system":"sec-edgar","filing":"0001741850-26-000002","document":"wk-form4_1783029712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1741850/000174185026000002/wk-form4_1783029712.xml","form_type":"4"}},{"id":717093,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":32607,"kind":"person","name":"KREHER NERISSA","position":1,"cik":"0001741850","reported_name":"KREHER NERISSA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T22:01:55.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":33582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued service on the Company's Board of Directors through such vesting date."}],"balance_after":33582,"source":{"system":"sec-edgar","filing":"0001741850-26-000002","document":"wk-form4_1783029712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1741850/000174185026000002/wk-form4_1783029712.xml","form_type":"4"}},{"id":718623,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-02T20:40:55.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":90000,"price":8.0279,"value":722511.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person as of September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.000 to $8.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,401 shares acquired on June 30, 2026 under the issuer's 2018 Employee Stock Purchase Plan, as amended."}],"balance_after":1691126,"source":{"system":"sec-edgar","filing":"0002031695-26-000008","document":"wk-form4_1783024852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000008/wk-form4_1783024852.xml","form_type":"4"}},{"id":717140,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-02T20:38:57.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":16666,"price":8.0319,"value":133859.6454,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.92 to $8.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,288 shares acquired on June 30, 2026 under the issuer's 2018 Employee Stock Purchase Plan, as amended."}],"balance_after":1161128,"source":{"system":"sec-edgar","filing":"0001652410-26-000014","document":"wk-form4_1783024734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000014/wk-form4_1783024734.xml","form_type":"4"}},{"id":747791,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T22:39:36.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":32996,"price":6.15,"value":202925.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":32996,"derivative":{"exercise_price":6.15,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":32996},"source":{"system":"sec-edgar","filing":"0001867096-26-000041","document":"wk-form4_1780699173.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000186709626000041/wk-form4_1780699173.xml","form_type":"4"}},{"id":747790,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40892,"kind":"person","name":"Kong Garheng","position":1,"cik":"0001435183","reported_name":"Kong Garheng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:39:36.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":238337,"source":{"system":"sec-edgar","filing":"0001867096-26-000041","document":"wk-form4_1780699173.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1435183/000186709626000041/wk-form4_1780699173.xml","form_type":"4"}},{"id":747740,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40878,"kind":"person","name":"PERSKY MARLA","position":1,"cik":"0001270354","reported_name":"PERSKY MARLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T22:29:31.000Z","date":"2026-06-04","kind":"grant","planned":true,"acquired":true,"shares":32996,"price":6.15,"value":202925.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":32996,"derivative":{"exercise_price":6.15,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":32996},"source":{"system":"sec-edgar","filing":"0001867096-26-000038","document":"wk-form4_1780698568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1270354/000186709626000038/wk-form4_1780698568.xml","form_type":"4"}},{"id":747739,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40878,"kind":"person","name":"PERSKY MARLA","position":1,"cik":"0001270354","reported_name":"PERSKY MARLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:29:31.000Z","date":"2026-06-04","kind":"grant","planned":true,"acquired":true,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":150693,"source":{"system":"sec-edgar","filing":"0001867096-26-000038","document":"wk-form4_1780698568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270354/000186709626000038/wk-form4_1780698568.xml","form_type":"4"}},{"id":747738,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40878,"kind":"person","name":"PERSKY MARLA","position":1,"cik":"0001270354","reported_name":"PERSKY MARLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:29:31.000Z","date":"2026-06-03","kind":"sale","planned":true,"acquired":false,"shares":15500,"price":5.8989,"value":91432.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.810 to $5.960, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":126500,"source":{"system":"sec-edgar","filing":"0001867096-26-000038","document":"wk-form4_1780698568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270354/000186709626000038/wk-form4_1780698568.xml","form_type":"4"}},{"id":748046,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40944,"kind":"person","name":"HALKUFF DAWN","position":1,"cik":"0001743658","reported_name":"HALKUFF DAWN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T22:18:14.000Z","date":"2026-06-04","kind":"grant","planned":true,"acquired":true,"shares":32996,"price":6.15,"value":202925.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":32996,"derivative":{"exercise_price":6.15,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":32996},"source":{"system":"sec-edgar","filing":"0001743658-26-000002","document":"wk-form4_1780697891.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1743658/000174365826000002/wk-form4_1780697891.xml","form_type":"4"}},{"id":748045,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40944,"kind":"person","name":"HALKUFF DAWN","position":1,"cik":"0001743658","reported_name":"HALKUFF DAWN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:18:14.000Z","date":"2026-06-04","kind":"grant","planned":true,"acquired":true,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":119193,"source":{"system":"sec-edgar","filing":"0001743658-26-000002","document":"wk-form4_1780697891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1743658/000174365826000002/wk-form4_1780697891.xml","form_type":"4"}},{"id":748044,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40944,"kind":"person","name":"HALKUFF DAWN","position":1,"cik":"0001743658","reported_name":"HALKUFF DAWN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:18:14.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":6.0943,"value":121886.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.960 to $6.170, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":95000,"source":{"system":"sec-edgar","filing":"0001743658-26-000002","document":"wk-form4_1780697891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743658/000174365826000002/wk-form4_1780697891.xml","form_type":"4"}},{"id":747892,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40914,"kind":"person","name":"BORMANN-KENNEDY BARBARA-JEAN ANNE","position":1,"cik":"0001635065","reported_name":"BORMANN-KENNEDY BARBARA-JEAN ANNE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T22:18:07.000Z","date":"2026-06-04","kind":"grant","planned":true,"acquired":true,"shares":32996,"price":6.15,"value":202925.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":32996,"derivative":{"exercise_price":6.15,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":32996},"source":{"system":"sec-edgar","filing":"0001635065-26-000002","document":"wk-form4_1780697885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1635065/000163506526000002/wk-form4_1780697885.xml","form_type":"4"}},{"id":747891,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40914,"kind":"person","name":"BORMANN-KENNEDY BARBARA-JEAN ANNE","position":1,"cik":"0001635065","reported_name":"BORMANN-KENNEDY BARBARA-JEAN ANNE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:18:07.000Z","date":"2026-06-04","kind":"grant","planned":true,"acquired":true,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":150693,"source":{"system":"sec-edgar","filing":"0001635065-26-000002","document":"wk-form4_1780697885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1635065/000163506526000002/wk-form4_1780697885.xml","form_type":"4"}},{"id":747890,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40914,"kind":"person","name":"BORMANN-KENNEDY BARBARA-JEAN ANNE","position":1,"cik":"0001635065","reported_name":"BORMANN-KENNEDY BARBARA-JEAN ANNE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:18:07.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":16000,"price":6.0942,"value":97507.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.970 to $6.170, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":126500,"source":{"system":"sec-edgar","filing":"0001635065-26-000002","document":"wk-form4_1780697885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635065/000163506526000002/wk-form4_1780697885.xml","form_type":"4"}},{"id":747777,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T22:17:57.000Z","date":"2026-06-04","kind":"grant","planned":true,"acquired":true,"shares":32996,"price":6.15,"value":202925.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":32996,"derivative":{"exercise_price":6.15,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":32996},"source":{"system":"sec-edgar","filing":"0001410781-26-000004","document":"wk-form4_1780697874.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410781/000141078126000004/wk-form4_1780697874.xml","form_type":"4"}},{"id":747776,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:17:57.000Z","date":"2026-06-04","kind":"grant","planned":true,"acquired":true,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":707276,"source":{"system":"sec-edgar","filing":"0001410781-26-000004","document":"wk-form4_1780697874.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410781/000141078126000004/wk-form4_1780697874.xml","form_type":"4"}},{"id":747775,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:17:57.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":6.0948,"value":91422.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.970 to $6.170, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":683083,"source":{"system":"sec-edgar","filing":"0001410781-26-000004","document":"wk-form4_1780697874.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410781/000141078126000004/wk-form4_1780697874.xml","form_type":"4"}},{"id":748699,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":41105,"kind":"person","name":"Brady James Aloysius","position":1,"cik":"0001916987","reported_name":"Brady James Aloysius","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-05T22:16:16.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":32996,"price":6.15,"value":202925.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":32996,"derivative":{"exercise_price":6.15,"expiration_date":"2036-06-04","underlying":"Common Stock","underlying_shares":32996},"source":{"system":"sec-edgar","filing":"0001916987-26-000004","document":"wk-form4_1780697773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1916987/000191698726000004/wk-form4_1780697773.xml","form_type":"4"}},{"id":748698,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":41105,"kind":"person","name":"Brady James Aloysius","position":1,"cik":"0001916987","reported_name":"Brady James Aloysius","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T22:16:16.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":24193,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 4, 2026 or the date of the Company's next annual meeting of stockholders, subject to continued service through such vesting date."}],"balance_after":113359,"source":{"system":"sec-edgar","filing":"0001916987-26-000004","document":"wk-form4_1780697773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1916987/000191698726000004/wk-form4_1780697773.xml","form_type":"4"}},{"id":754022,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-02T22:05:04.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":16667,"price":6.0588,"value":100982.0196,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.980 to $6.180, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1176506,"source":{"system":"sec-edgar","filing":"0001652410-26-000012","document":"wk-form4_1780437901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000012/wk-form4_1780437901.xml","form_type":"4"}},{"id":795259,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-01T21:50:33.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":16667,"price":6.2282,"value":103805.4094,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.100 to $6.320, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1193173,"source":{"system":"sec-edgar","filing":"0001652410-26-000010","document":"wk-form4_1777672230.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000010/wk-form4_1777672230.xml","form_type":"4"}},{"id":815541,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-03T21:45:24.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":16667,"price":5.9914,"value":99858.6638,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.890 to $6.085, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1209840,"source":{"system":"sec-edgar","filing":"0001652410-26-000008","document":"wk-form4_1775252722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000008/wk-form4_1775252722.xml","form_type":"4"}},{"id":823501,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":41105,"kind":"person","name":"Brady James Aloysius","position":1,"cik":"0001916987","reported_name":"Brady James Aloysius","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-01T21:54:24.000Z","date":"2026-03-30","kind":"sale","planned":true,"acquired":false,"shares":10834,"price":5.5414,"value":60035.5276,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.290 to $5.630, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":89166,"source":{"system":"sec-edgar","filing":"0001916987-26-000002","document":"wk-form4_1775080462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1916987/000191698726000002/wk-form4_1775080462.xml","form_type":"4"}},{"id":842024,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-16T22:11:35.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":false,"shares":4,"price":3.94,"value":15.76,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received the stock options on August 26, 2020 pursuant to an award under the 2018 Plan. 50% of the options vested on the first anniversary of the vesting commencement date, 25% of the options vested on the 18-month anniversary of the vesting commencement date, and the remaining 25% of options vested on the two-year anniversary of the vesting commencement date, in each case subject to continued employment through such vesting date."}],"balance_after":79996,"derivative":{"exercise_price":3.94,"expiration_date":"2030-08-26","underlying":"Common Stock","underlying_shares":4},"source":{"system":"sec-edgar","filing":"0002031695-26-000006","document":"wk-form4_1773699093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000006/wk-form4_1773699093.xml","form_type":"4"}},{"id":842023,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-16T22:11:35.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":false,"shares":48894,"price":4.09,"value":199976.46,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received the stock options on December 10, 2020 pursuant to an award under the Company's 2018 Stock Option/Stock Issuance Plan (the \"2018 Plan\"). 50% of the options vested on the first\nanniversary of the vesting commencement date, and the remaining 50% of options vested on the second anniversary of the vesting commencement date, in each case subject to continued employment\nthrough such vesting date."}],"balance_after":43773,"derivative":{"exercise_price":4.09,"expiration_date":"2027-12-10","underlying":"Common Stock","underlying_shares":48894},"source":{"system":"sec-edgar","filing":"0002031695-26-000006","document":"wk-form4_1773699093.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000006/wk-form4_1773699093.xml","form_type":"4"}},{"id":842022,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-16T22:11:35.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":true,"shares":4,"price":3.94,"value":15.76,"ownership":{"direct":true},"balance_after":1777725,"source":{"system":"sec-edgar","filing":"0002031695-26-000006","document":"wk-form4_1773699093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000006/wk-form4_1773699093.xml","form_type":"4"}},{"id":842021,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-16T22:11:35.000Z","date":"2026-03-12","kind":"exercise","planned":false,"acquired":true,"shares":48894,"price":4.09,"value":199976.46,"ownership":{"direct":true},"balance_after":1777721,"source":{"system":"sec-edgar","filing":"0002031695-26-000006","document":"wk-form4_1773699093.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000006/wk-form4_1773699093.xml","form_type":"4"}},{"id":858836,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T00:18:28.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":14036,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The reporting person received the stock options on January 31, 2018 pursuant to an award under the Company's 2011 Stock Option/Stock Issuance Plan. 25% of the options vested on the first\nanniversary of the vesting commencement date, and the remaining 75% of options vested in equal monthly installments over the following three (3) years, in each case subject to continued employment through such\nvesting date."}],"balance_after":0,"derivative":{"exercise_price":5.93,"expiration_date":"2028-01-31","underlying":"Common Stock","underlying_shares":14036},"source":{"system":"sec-edgar","filing":"0001875714-26-000004","document":"wk-form4_1772756306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000004/wk-form4_1772756306.xml","form_type":"4"}},{"id":858835,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T00:18:28.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":false,"shares":27891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person received the stock options on December 10, 2020 pursuant to an award under the Company's 2018 Stock Option/Stock Issuance Plan. 50% of the options vested on the first\nanniversary of the vesting commencement date, and the remaining 50% of options vested on the second anniversary of the vesting commencement date, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":4.09,"expiration_date":"2030-12-10","underlying":"Common Stock","underlying_shares":27891},"source":{"system":"sec-edgar","filing":"0001875714-26-000004","document":"wk-form4_1772756306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000004/wk-form4_1772756306.xml","form_type":"4"}},{"id":858834,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-06T00:18:28.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":14036,"price":5.93,"value":83233.48,"ownership":{"direct":true},"balance_after":1408940,"source":{"system":"sec-edgar","filing":"0001875714-26-000004","document":"wk-form4_1772756306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000004/wk-form4_1772756306.xml","form_type":"4"}},{"id":858833,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-06T00:18:28.000Z","date":"2026-03-05","kind":"exercise","planned":false,"acquired":true,"shares":27891,"price":4.09,"value":114074.19,"ownership":{"direct":true},"balance_after":1394904,"source":{"system":"sec-edgar","filing":"0001875714-26-000004","document":"wk-form4_1772756306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000004/wk-form4_1772756306.xml","form_type":"4"}},{"id":860633,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T22:28:47.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":100,"price":7.06,"value":706.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1226507,"source":{"system":"sec-edgar","filing":"0001652410-26-000006","document":"wk-form4_1772663325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000006/wk-form4_1772663325.xml","form_type":"4"}},{"id":860632,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-04T22:28:47.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":16567,"price":6.2401,"value":103379.7367,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.920 to $6.910, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1226607,"source":{"system":"sec-edgar","filing":"0001652410-26-000006","document":"wk-form4_1772663325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000006/wk-form4_1772663325.xml","form_type":"4"}},{"id":882333,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":64750,"kind":"person","name":"Nguyen Anh Tu","position":1,"cik":"0002058704","reported_name":"Nguyen Anh Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-25T18:03:14.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":29300,"price":6.88,"value":201584.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of February 24, 2026."}],"balance_after":395023,"source":{"system":"sec-edgar","filing":"0002058704-26-000004","document":"wk-form4_1772060591.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058704/000205870426000004/wk-form4_1772060591.xml","form_type":"4"}},{"id":924549,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T23:13:18.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":639639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service through such vesting date."}],"balance_after":639639,"derivative":{"exercise_price":7.36,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":639639},"source":{"system":"sec-edgar","filing":"0001553595-26-000004","document":"wk-form4_1770073996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000004/wk-form4_1770073996.xml","form_type":"4"}},{"id":924548,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:13:18.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":110750,"price":7.36,"value":815120.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":2935578,"source":{"system":"sec-edgar","filing":"0001553595-26-000004","document":"wk-form4_1770073996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000004/wk-form4_1770073996.xml","form_type":"4"}},{"id":924547,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:13:18.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":111621,"price":7.36,"value":821530.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":3046328,"source":{"system":"sec-edgar","filing":"0001553595-26-000004","document":"wk-form4_1770073996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000004/wk-form4_1770073996.xml","form_type":"4"}},{"id":924546,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:13:18.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":118134,"price":7.36,"value":869466.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":3157949,"source":{"system":"sec-edgar","filing":"0001553595-26-000004","document":"wk-form4_1770073996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000004/wk-form4_1770073996.xml","form_type":"4"}},{"id":924545,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:13:18.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":478436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued employment through such vesting date."}],"balance_after":3276083,"source":{"system":"sec-edgar","filing":"0001553595-26-000004","document":"wk-form4_1770073996.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000004/wk-form4_1770073996.xml","form_type":"4"}},{"id":925548,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T23:12:53.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":225225,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service through such vesting date."}],"balance_after":225225,"derivative":{"exercise_price":7.36,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":225225},"source":{"system":"sec-edgar","filing":"0002031695-26-000004","document":"wk-form4_1770073970.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000004/wk-form4_1770073970.xml","form_type":"4"}},{"id":925547,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:53.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":27319,"price":7.36,"value":201067.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1727827,"source":{"system":"sec-edgar","filing":"0002031695-26-000004","document":"wk-form4_1770073970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000004/wk-form4_1770073970.xml","form_type":"4"}},{"id":925546,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:53.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":30289,"price":7.36,"value":222927.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1755146,"source":{"system":"sec-edgar","filing":"0002031695-26-000004","document":"wk-form4_1770073970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000004/wk-form4_1770073970.xml","form_type":"4"}},{"id":925545,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:53.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":68454,"price":7.36,"value":503821.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1785435,"source":{"system":"sec-edgar","filing":"0002031695-26-000004","document":"wk-form4_1770073970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000004/wk-form4_1770073970.xml","form_type":"4"}},{"id":925544,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:53.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":168463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued employment through such vesting date."}],"balance_after":1853889,"source":{"system":"sec-edgar","filing":"0002031695-26-000004","document":"wk-form4_1770073970.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000004/wk-form4_1770073970.xml","form_type":"4"}},{"id":925440,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T23:12:20.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":207207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service through such vesting date."}],"balance_after":207207,"derivative":{"exercise_price":7.36,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":207207},"source":{"system":"sec-edgar","filing":"0001875714-26-000002","document":"wk-form4_1770073937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000002/wk-form4_1770073937.xml","form_type":"4"}},{"id":925439,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:20.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":27319,"price":7.36,"value":201067.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1367013,"source":{"system":"sec-edgar","filing":"0001875714-26-000002","document":"wk-form4_1770073937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000002/wk-form4_1770073937.xml","form_type":"4"}},{"id":925438,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:20.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":66450,"price":7.36,"value":489072.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1394332,"source":{"system":"sec-edgar","filing":"0001875714-26-000002","document":"wk-form4_1770073937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000002/wk-form4_1770073937.xml","form_type":"4"}},{"id":925437,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:20.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":111765,"price":7.36,"value":822590.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1460782,"source":{"system":"sec-edgar","filing":"0001875714-26-000002","document":"wk-form4_1770073937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000002/wk-form4_1770073937.xml","form_type":"4"}},{"id":925436,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18001,"kind":"person","name":"Pieper Steven","position":1,"cik":"0001875714","reported_name":"Pieper Steven","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:12:20.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":154986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued employment through such vesting date."}],"balance_after":1572547,"source":{"system":"sec-edgar","filing":"0001875714-26-000002","document":"wk-form4_1770073937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1875714/000187571426000002/wk-form4_1770073937.xml","form_type":"4"}},{"id":924480,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T23:11:11.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":162162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service through such vesting date."}],"balance_after":162162,"derivative":{"exercise_price":7.36,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":162162},"source":{"system":"sec-edgar","filing":"0001652410-26-000004","document":"wk-form4_1770073868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000004/wk-form4_1770073868.xml","form_type":"4"}},{"id":924479,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:11:11.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":16667,"price":7.4487,"value":124147.4829,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.250 to $7.590, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1243174,"source":{"system":"sec-edgar","filing":"0001652410-26-000004","document":"wk-form4_1770073868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000004/wk-form4_1770073868.xml","form_type":"4"}},{"id":924478,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:11:11.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":24266,"price":7.36,"value":178597.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1259841,"source":{"system":"sec-edgar","filing":"0001652410-26-000004","document":"wk-form4_1770073868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000004/wk-form4_1770073868.xml","form_type":"4"}},{"id":924477,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:11:11.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":46914,"price":7.36,"value":345287.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1284107,"source":{"system":"sec-edgar","filing":"0001652410-26-000004","document":"wk-form4_1770073868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000004/wk-form4_1770073868.xml","form_type":"4"}},{"id":924476,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:11:11.000Z","date":"2026-01-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":98375,"price":7.36,"value":724040.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026."}],"balance_after":1331021,"source":{"system":"sec-edgar","filing":"0001652410-26-000004","document":"wk-form4_1770073868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000004/wk-form4_1770073868.xml","form_type":"4"}},{"id":924475,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T23:11:11.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":121293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued employment through such vesting date."}],"balance_after":1429396,"source":{"system":"sec-edgar","filing":"0001652410-26-000004","document":"wk-form4_1770073868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000004/wk-form4_1770073868.xml","form_type":"4"}},{"id":925589,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":64750,"kind":"person","name":"Nguyen Anh Tu","position":1,"cik":"0002058704","reported_name":"Nguyen Anh Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-02T18:11:54.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":162162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These stock options were acquired pursuant to a grant under the Plan. These stock options shall vest in equal annual installments over three years, subject to continued service through such vesting date."}],"balance_after":162162,"derivative":{"exercise_price":7.36,"expiration_date":"2036-01-30","underlying":"Common Stock","underlying_shares":162162},"source":{"system":"sec-edgar","filing":"0002058704-26-000002","document":"wk-form4_1770073911.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2058704/000205870426000002/wk-form4_1770073911.xml","form_type":"4"}},{"id":925588,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":64750,"kind":"person","name":"Nguyen Anh Tu","position":1,"cik":"0002058704","reported_name":"Nguyen Anh Tu","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-02T18:11:54.000Z","date":"2026-01-30","kind":"grant","planned":false,"acquired":true,"shares":121293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit grant under the Company's 2018 Stock Option and Incentive Plan (the \"Plan\"). Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years, subject to continued employment through such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,030 shares acquired on December 31, 2025 under the issuer's 2018 Employee Stock Purchase Plan, as amended."}],"balance_after":424323,"source":{"system":"sec-edgar","filing":"0002058704-26-000002","document":"wk-form4_1770073911.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2058704/000205870426000002/wk-form4_1770073911.xml","form_type":"4"}},{"id":942449,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-09T22:34:56.000Z","date":"2026-01-08","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":8,"value":120000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":1685426,"source":{"system":"sec-edgar","filing":"0002031695-26-000002","document":"wk-form4_1767998094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169526000002/wk-form4_1767998094.xml","form_type":"4"}},{"id":945774,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T23:14:28.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":2900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person received the stock options on August 26, 2020 pursuant to an award under the Company's 2018 Stock Option/Stock Issuance Plan. 25% of the options vested on the first\nanniversary of the vesting commencement date, and the remaining 75% of options vested in equal monthly installments over the following three (3) years subject to continued employment through such\nvesting date."}],"balance_after":97100,"derivative":{"exercise_price":3.94,"expiration_date":"2030-08-26","underlying":"Common Stock","underlying_shares":2900},"source":{"system":"sec-edgar","filing":"0001553595-26-000002","document":"wk-form4_1767741265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000002/wk-form4_1767741265.xml","form_type":"4"}},{"id":945773,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T23:14:28.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":25136,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person received the stock options on June 12, 2017 pursuant to an award under the Company's 2011 Stock Option/Stock Issuance Plan. 25% of the options vested on the first\nanniversary of the vesting commencement date, and the remaining 75% of options vested in equal monthly installments over the following three (3) years subject to continued employment through such\nvesting date."}],"balance_after":0,"derivative":{"exercise_price":1.55,"expiration_date":"2027-06-12","underlying":"Common Stock","underlying_shares":25136},"source":{"system":"sec-edgar","filing":"0001553595-26-000002","document":"wk-form4_1767741265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000002/wk-form4_1767741265.xml","form_type":"4"}},{"id":945772,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-06T23:14:28.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":64265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received the stock options on February 4, 2017 pursuant to an award under the Company's 2011 Stock Option/Stock Issuance Plan. 25% of the options vested on the first\nanniversary of the vesting commencement date, and the remaining 75% of options vested in equal monthly installments over the following three (3) years subject to continued employment through such\nvesting date."}],"balance_after":0,"derivative":{"exercise_price":1.55,"expiration_date":"2027-02-04","underlying":"Common Stock","underlying_shares":64265},"source":{"system":"sec-edgar","filing":"0001553595-26-000002","document":"wk-form4_1767741265.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000002/wk-form4_1767741265.xml","form_type":"4"}},{"id":945771,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T23:14:28.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":2900,"price":3.94,"value":11426.0,"ownership":{"direct":true},"balance_after":2797647,"source":{"system":"sec-edgar","filing":"0001553595-26-000002","document":"wk-form4_1767741265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000002/wk-form4_1767741265.xml","form_type":"4"}},{"id":945770,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T23:14:28.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":25136,"price":1.55,"value":38960.8,"ownership":{"direct":true},"balance_after":2794747,"source":{"system":"sec-edgar","filing":"0001553595-26-000002","document":"wk-form4_1767741265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000002/wk-form4_1767741265.xml","form_type":"4"}},{"id":945769,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T23:14:28.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":64265,"price":1.55,"value":99610.75,"ownership":{"direct":true},"balance_after":2769611,"source":{"system":"sec-edgar","filing":"0001553595-26-000002","document":"wk-form4_1767741265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000002/wk-form4_1767741265.xml","form_type":"4"}},{"id":945768,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-06T23:14:28.000Z","date":"2026-01-05","kind":"sale","planned":false,"acquired":false,"shares":24907,"price":7.0766,"value":176256.8762,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.040 to $7.350, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":2705346,"source":{"system":"sec-edgar","filing":"0001553595-26-000002","document":"wk-form4_1767741265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359526000002/wk-form4_1767741265.xml","form_type":"4"}},{"id":949915,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-05T23:01:59.000Z","date":"2026-01-02","kind":"sale","planned":true,"acquired":false,"shares":16667,"price":7.4264,"value":123775.8088,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.280 to $7.740, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,627 shares acquired on June 30, 2025 and 1,967 shares acquired on December 31, 2025 under the issuer's 2018 Employee Stock Purchase Plan, as amended."}],"balance_after":1308103,"source":{"system":"sec-edgar","filing":"0001652410-26-000002","document":"wk-form4_1767654116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241026000002/wk-form4_1767654116.xml","form_type":"4"}},{"id":961939,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-19T22:17:45.000Z","date":"2025-12-19","kind":"sale","planned":false,"acquired":false,"shares":135400,"price":7.2158,"value":977019.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.200 to $7.275, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":698083,"source":{"system":"sec-edgar","filing":"0001410781-25-000006","document":"wk-form4_1766182662.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410781/000141078125000006/wk-form4_1766182662.xml","form_type":"4"}},{"id":969403,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40914,"kind":"person","name":"BORMANN-KENNEDY BARBARA-JEAN ANNE","position":1,"cik":"0001635065","reported_name":"BORMANN-KENNEDY BARBARA-JEAN ANNE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-15T22:24:22.000Z","date":"2025-12-12","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":7.0943,"value":106414.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.000 to $7.180, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":142500,"source":{"system":"sec-edgar","filing":"0001635065-25-000004","document":"wk-form4_1765837458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1635065/000163506525000004/wk-form4_1765837458.xml","form_type":"4"}},{"id":983170,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-12-02T22:14:20.000Z","date":"2025-12-01","kind":"sale","planned":true,"acquired":false,"shares":16667,"price":7.0067,"value":116780.6689,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.930 to $7.120, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1320176,"source":{"system":"sec-edgar","filing":"0001652410-25-000005","document":"wk-form4_1764713658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241025000005/wk-form4_1764713658.xml","form_type":"4"}},{"id":997529,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-17T22:58:52.000Z","date":"2025-11-14","kind":"exercise","planned":false,"acquired":false,"shares":87100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received the stock options on February 7, 2017 pursuant to an award under the Company's 2011 Stock Option/Stock Issuance Plan. 25% of the options vested on the first anniversary of the vesting commencement date, and the remaining 75% of options vested in equal monthly installments over the following three (3) years subject to continued employment through such vesting date."}],"balance_after":64265,"derivative":{"exercise_price":1.55,"expiration_date":"2027-02-03","underlying":"Common Stock","underlying_shares":87100},"source":{"system":"sec-edgar","filing":"0001553595-25-000004","document":"wk-form4_1763420330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359525000004/wk-form4_1763420330.xml","form_type":"4"}},{"id":997528,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-17T22:58:52.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":false,"shares":8970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The reporting person received the stock options on February 7, 2017 pursuant to an award under the Company's 2011 Stock Option/Stock Issuance Plan. 25% of the options vested on the first anniversary of the vesting commencement date, and the remaining 75% of options vested in equal monthly installments over the following three (3) years subject to continued employment through such vesting date."}],"balance_after":151365,"derivative":{"exercise_price":1.55,"expiration_date":"2027-02-03","underlying":"Common Stock","underlying_shares":8970},"source":{"system":"sec-edgar","filing":"0001553595-25-000004","document":"wk-form4_1763420330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359525000004/wk-form4_1763420330.xml","form_type":"4"}},{"id":997527,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-17T22:58:52.000Z","date":"2025-11-14","kind":"exercise","planned":false,"acquired":true,"shares":87100,"price":1.55,"value":135005.0,"ownership":{"direct":true},"balance_after":2730253,"source":{"system":"sec-edgar","filing":"0001553595-25-000004","document":"wk-form4_1763420330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359525000004/wk-form4_1763420330.xml","form_type":"4"}},{"id":997526,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-17T22:58:52.000Z","date":"2025-11-13","kind":"sale","planned":false,"acquired":false,"shares":23242,"price":7.4607,"value":173401.5894,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.260 to $7.740, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":2643153,"source":{"system":"sec-edgar","filing":"0001553595-25-000004","document":"wk-form4_1763420330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359525000004/wk-form4_1763420330.xml","form_type":"4"}},{"id":997525,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-17T22:58:52.000Z","date":"2025-11-13","kind":"exercise","planned":false,"acquired":true,"shares":8970,"price":1.55,"value":13903.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":2666395,"source":{"system":"sec-edgar","filing":"0001553595-25-000004","document":"wk-form4_1763420330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000155359525000004/wk-form4_1763420330.xml","form_type":"4"}},{"id":999802,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":17834,"kind":"person","name":"Hecht Beth","position":1,"cik":"0001652410","reported_name":"Hecht Beth","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-11-13T23:59:35.000Z","date":"2025-11-11","kind":"sale","planned":true,"acquired":false,"shares":16667,"price":7.3976,"value":123295.7992,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.290 to $7.750, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":1336843,"source":{"system":"sec-edgar","filing":"0001652410-25-000003","document":"wk-form4_1763078372.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1652410/000165241025000003/wk-form4_1763078372.xml","form_type":"4"}},{"id":1024959,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-03T21:21:11.000Z","date":"2025-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":733,"price":8.31,"value":6091.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of October 2, 2025."}],"balance_after":1700426,"source":{"system":"sec-edgar","filing":"0002031695-25-000006","document":"wk-form4_1759526468.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169525000006/wk-form4_1759526468.xml","form_type":"4"}},{"id":1040703,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-09-15T21:33:15.000Z","date":"2025-09-11","kind":"other","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Charles R. McCulloch Trust dated 1990"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person is trustee of the Charles R. McCulloch Trust, of which he is a beneficiary. On September 11, 2025, the reporting person caused the trust to distribute 2,000 shares of the Issuer's common stock to a beneficiary of the trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.  No sale of shares occurred in the transfer."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0002031695-25-000004","document":"wk-form4_1757971992.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000203169525000004/wk-form4_1757971992.xml","form_type":"4"}},{"id":1041341,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40878,"kind":"person","name":"PERSKY MARLA","position":1,"cik":"0001270354","reported_name":"PERSKY MARLA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T21:09:26.000Z","date":"2025-09-11","kind":"sale","planned":true,"acquired":false,"shares":15500,"price":7.7168,"value":119610.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.650 to $7.840, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":142000,"source":{"system":"sec-edgar","filing":"0001867096-25-000147","document":"wk-form4_1757711362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270354/000186709625000147/wk-form4_1757711362.xml","form_type":"4"}},{"id":1052700,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":45619,"kind":"person","name":"SHERMAN JEFFREY W","position":1,"cik":"0001230482","reported_name":"SHERMAN JEFFREY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-29T21:21:38.000Z","date":"2025-08-28","kind":"exercise","planned":false,"acquired":false,"shares":47040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 1, 2016, the reporting person was granted an option to purchase shares of Strongbridge Biopharma plc (\"Strongbridge\") which were assumed by Issuer in connection with the acquisition of Strongbridge. The options vested in full on October 5, 2021."}],"balance_after":0,"derivative":{"exercise_price":6.66,"expiration_date":"2026-10-01","underlying":"Common Stock","underlying_shares":47040},"source":{"system":"sec-edgar","filing":"0001867096-25-000145","document":"wk-form4_1756502494.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1230482/000186709625000145/wk-form4_1756502494.xml","form_type":"4"}},{"id":1052699,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":45619,"kind":"person","name":"SHERMAN JEFFREY W","position":1,"cik":"0001230482","reported_name":"SHERMAN JEFFREY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T21:21:38.000Z","date":"2025-08-28","kind":"sale","planned":false,"acquired":false,"shares":42232,"price":7.9209,"value":334515.4488,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.920 to $7.935, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":219188,"source":{"system":"sec-edgar","filing":"0001867096-25-000145","document":"wk-form4_1756502494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1230482/000186709625000145/wk-form4_1756502494.xml","form_type":"4"}},{"id":1052698,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":45619,"kind":"person","name":"SHERMAN JEFFREY W","position":1,"cik":"0001230482","reported_name":"SHERMAN JEFFREY W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-29T21:21:38.000Z","date":"2025-08-28","kind":"exercise","planned":false,"acquired":true,"shares":47040,"price":6.66,"value":313286.4,"ownership":{"direct":true},"balance_after":261420,"source":{"system":"sec-edgar","filing":"0001867096-25-000145","document":"wk-form4_1756502494.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230482/000186709625000145/wk-form4_1756502494.xml","form_type":"4"}},{"id":1065203,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":13228,"kind":"person","name":"JOHNSON JOHN","position":1,"cik":"0001410781","reported_name":"JOHNSON JOHN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-15T20:57:39.000Z","date":"2025-08-13","kind":"sale","planned":false,"acquired":false,"shares":107500,"price":7.3159,"value":786459.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.250 to $7.420, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":833483,"source":{"system":"sec-edgar","filing":"0001867096-25-000141","document":"wk-form4_1755291454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410781/000186709625000141/wk-form4_1755291454.xml","form_type":"4"}},{"id":1067828,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":40944,"kind":"person","name":"HALKUFF DAWN","position":1,"cik":"0001743658","reported_name":"HALKUFF DAWN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-13T20:47:42.000Z","date":"2025-08-12","kind":"sale","planned":false,"acquired":false,"shares":42500,"price":7.2759,"value":309225.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.190 to $7.450, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":115000,"source":{"system":"sec-edgar","filing":"0001867096-25-000138","document":"wk-form4_1755118058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743658/000186709625000138/wk-form4_1755118058.xml","form_type":"4"}},{"id":1076061,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":20765,"kind":"person","name":"Shannon John Patrick Jr","position":1,"cik":"0001553595","reported_name":"Shannon John Patrick Jr","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-04T20:24:53.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":36918,"price":5.38,"value":198618.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 7,225 shares that were purchased on June 30, 2025, due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan"}],"balance_after":2657425,"source":{"system":"sec-edgar","filing":"0001867096-25-000124","document":"wk-form4_1754339089.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553595/000186709625000124/wk-form4_1754339089.xml","form_type":"4"}},{"id":1076482,"issuer":{"id":4670,"kind":"organization","name":"Xeris Biopharma Holdings, Inc.","symbol":"XERS"},"owners":[{"id":18038,"kind":"person","name":"McCulloch Kevin","position":1,"cik":"0002031695","reported_name":"McCulloch Kevin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-08-04T20:24:34.000Z","date":"2025-08-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":14651,"price":5.38,"value":78822.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares include 7,225 shares that were purchased on June 30, 2025 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan."}],"balance_after":1701159,"source":{"system":"sec-edgar","filing":"0001867096-25-000123","document":"wk-form4_1754339070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2031695/000186709625000123/wk-form4_1754339070.xml","form_type":"4"}}],"next_cursor":"2025-08-04T20:24:34.000000Z,1076482"}